Activated protein C up-regulates procoagulant tissue factor activity on endothelial cells by shedding the TFPI Kunitz 1 domain

Blood

Volumn 117, Issue 23, 2011, Pages 6338-6346

  Schuepbach, Reto A ^a,b   Velez, Kara ^a   Riewald, Matthias ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ALANINE; BLOOD CLOTTING FACTOR 10A; LYSINE; PROCOAGULANT; PROTEINASE ACTIVATED RECEPTOR; RECEPTOR PROTEIN; SERINE PROTEINASE INHIBITOR; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION;

EID: 79959459236     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-10-316257     Document Type: Article

References (42)

1. Nemerson Y. The tissue factor pathway of blood coagulation. Semin Hematol. 1992;29(3):170-176.
2. Bach RR. Tissue factor encryption. Arterioscler Thromb Vasc Biol. 2006;26(3):456-461.
3. Broze GJ, Jr Tissue factor pathway inhibitor. Thromb Haemost. 1995;74(1):90-93.
4. Crawley JT, Lane DA. The haemostatic role of tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol. 2008;28(2):233-242. (Pubitemid 351161194)
5. Esmon CT. The protein C pathway. Chest. 2003; 124(3 suppl):26S-32S. (Pubitemid 37128433)
6. Dahlbäck B, Villoutreix BO. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition. Arterioscler Thromb Vasc Biol. 2005;25(7):1311-1320. (Pubitemid 40923345)
7. Esmon CT, Xu J, Gu JM, et al. Endothelial protein C receptor. Thromb Haemost. 1999;82(2):251-258.
8. Coughlin SR. Thrombin signalling and proteaseactivated receptors. Nature. 2000;407(6801):258-264.
9. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science. 2002;296(5574):1880-1882. (Pubitemid 34596276)
10. Feistritzer C, Riewald M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood. 2005;105(8):3178-3184.
11. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood. 2007;109(8): 3161-3172. (Pubitemid 46572500)
12. Feistritzer C, Schuepbach RA, Mosnier LO, et al. Protective signaling by activated protein C is mechanistically linked to protein C activation on endothelial cells. J Biol Chem. 2006;281(29): 20077-20084. (Pubitemid 44065782)
13. Kerschen EJ, Fernandez JA, Cooley BC, et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med. 2007;204(10):2439-2448. (Pubitemid 47529328)
14. Niessen F, Furlan-Freguia C, Fernandez JA, et al. Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality. Blood. 2009;113(12):2859-2866.
15. Schuepbach RA, Feistritzer C, Fernandez JA, Griffin JH, Riewald M. Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1. Thromb Haemost. 2009;101(4):724-733.
16. Brox JH, Osterud B, Bjorklid E, Fenton JW 2nd. Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets. Br J Haematol. 1984;57(2): 239-246. (Pubitemid 14106399)
17. Østerud B, Bjorklid E. Sources of tissue factor. Semin Thromb Hemost. 2006;32(1):11-23.
18. Riewald M, Ruf W. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci U S A. 2001; 98(14):7742-7747. (Pubitemid 32642631)
19. Ye X, Fukudome K, Tsuneyoshi N, et al. The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries. Biochem Biophys Res Commun. 1999;259(3): 671-677. (Pubitemid 29335592)
20. O'Brien PJ, Prevost N, Molino M, et al. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem. 2000;275(18):13502-13509. (Pubitemid 30257415)
21. Heeb MJ, Schwarz HP, White T, Lammle B, Berrettini M, Griffin JH. Immunoblotting studies of the molecular forms of protein C in plasma. Thromb Res. 1988;52(1):33-43. (Pubitemid 18267485)
22. Schuepbach RA, Riewald M. Coagulation factor Xa cleaves protease-activated receptor-1 and mediates signaling dependent on binding to the endothelial protein C receptor. J Thromb Haemost. 2010;8(2):379-388.
23. Pendurthi UR, Ghosh S, Mandal SK, Rao LV. Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood. 2007;110(12): 3900-3908. (Pubitemid 350248445)
24. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A. 1983;80(12):3734-3737. (Pubitemid 13063134)
25. Zhang J, Piro O, Lu L, Broze GJ Jr. Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor. Circulation. 2003;108(5):623-627. (Pubitemid 36961180)
26. Schuepbach RA, Feistritzer C, Brass LF, Riewald M. Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin. Blood. 2008;111(5):2667-2673.
27. Schabbauer G, Tencati M, Pedersen B, Pawlinski R, Mackman N. PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice. Arterioscler Thromb Vasc Biol. 2004;24(10):1963-1969. (Pubitemid 39350320)
28. Guo H, Liu D, Gelbard H, et al. Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron. 2004;41(4):563-572. (Pubitemid 38253068)
29. Yang XV, Banerjee Y, Fernandez JA, et al. Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells. Proc Natl Acad Sci U S A. 2009;106(1):274-279.
30. Piro O, Broze GJ Jr. Comparison of cell-surface TFPIalpha and beta. J Thromb Haemost. 2005; 3(12):2677-2683.
31. Girard TJ, Warren LA, Novotny WF, et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature. 1989;338(6215):518-520. (Pubitemid 19107996)
32. Lu G, Broze GJ Jr, Krishnaswamy S. Formation of factors IXa and Xa by the extrinsic pathway: differential regulation by tissue factor pathway inhibitor and antithrombin III. J Biol Chem. 2004; 279(17):17241-17249. (Pubitemid 38560482)
33. Salemink I, Franssen J, Willems GM, et al. Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activity. Thromb Haemost. 1998;80(2):273-280. (Pubitemid 28393623)
34. Sevinsky JR, Rao LV, Ruf W. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol. 1996;133(2):293-304. (Pubitemid 26131614)
35. Russo A, Soh UJ, Paing MM, Arora P, Trejo J. Caveolae are required for protease-selective signaling by protease-activated receptor-1. Proc Natl Acad Sci U S A. 2009;106(15):6393-6397.
36. Maroney SA, Cunningham AC, Ferrel J, et al. A GPI-anchored co-receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression. J Thromb Haemost. 2006;4(5):1114-1124.
37. Hamamoto T, Kisiel W. Full-length human tissue factor pathway inhibitor inhibits human activated protein C in the presence of heparin. Thromb Res. 1995;80(4):291-297.
38. Hackeng TM, Tans G, Koppelman SJ, de Groot PG, Rosing J, Bouma BN. Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than alpha-thrombin. Biochem J. 1996;319(Pt 2):399-405. (Pubitemid 26372195)
39. Toussaint S, Gerlach H. Activated protein C for sepsis. N Engl J Med. 2009;361(27):2646-2652.
40. Massberg S, Grahl L, von Bruehl ML, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med. 2010; 16(8):887-896.
41. Maroney SA, Ferrel JP, Pan S, et al. Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice. J Thromb Haemost. 2009;7(7):1106-1113.
42. Holroyd EW, Simari RD. Interdependent biological systems, multi-functional molecules: the evolving role of tissue factor pathway inhibitor beyond anti-coagulation. Thromb Res. 2010; 125(suppl 1):S57-S59.